Related Experiment Video

Updated: May 30, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Immunoreactivity to caspase-3, caspase-7, caspase-8, and caspase-9 forms is frequently lost in human prostate tumors

Gonzalo Rodríguez-Berriguete1, Laura Galvis, Benito Fraile

  • 1Department of Cell Biology and Genetics, University of Alcalá, 28871 Alcalá de Henares, Madrid, Spain. gonzalo.rodriguezb@uah.es

Human Pathology
|August 2, 2011
PubMed

Insights

Caspase expression is reduced in prostate cancer and its precursor stages. This loss of caspase activity may serve as a diagnostic marker and a therapeutic target for prostate cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Caspases are crucial enzymes regulating apoptosis (programmed cell death).
  • Altered caspase expression is implicated in cancer development by disrupting the balance between cell proliferation and death.
  • Prostate cancer progression involves complex molecular changes affecting cell death pathways.

Purpose of the Study:

  • To investigate alterations in caspase expression within human prostate tissues.
  • To correlate caspase expression levels with different stages of prostate disease, including normal, benign hyperplasia, high-grade intraepithelial neoplasia, and prostate cancer.
  • To assess the potential of caspase expression as a biomarker for prostate cancer diagnosis and progression.

Main Methods:

  • Immunohistochemistry was employed to analyze the expression of key caspases (pro-caspase-3, pro-caspase-8, pro-caspase-9, cleaved caspase-3, cleaved caspase-8, and caspase-7).
  • Expression levels were examined in epithelial cells from normal prostate tissue and various pathological conditions (benign prostatic hyperplasia, high-grade intraepithelial neoplasia, prostate cancer).
  • Caspase expression data were correlated with clinicopathological parameters such as PSA levels, Gleason scores, and biochemical recurrence.

Main Results:

  • A significant decrease in the percentage of positive samples for all analyzed caspases was observed in prostate cancer compared to normal prostate epithelium.
  • Benign prostatic hyperplasia and high-grade intraepithelial neoplasia tissues showed caspase expression patterns qualitatively similar to those in prostate cancer.
  • Reduced caspase expression was evident even at the premalignant stage (high-grade intraepithelial neoplasia).

Conclusions:

  • Caspase expression is substantially reduced in prostate malignant cells, indicating an early event in tumorigenesis.
  • The loss of caspase expression in prostate tissues may serve as a valuable diagnostic marker for prostate cancer.
  • Therapeutic strategies aimed at restoring or enhancing caspase activity could offer a novel approach for treating prostate cancer.

More Related Videos

Quantification of Immunostained Caspase-9 in Retinal Tissue05:18

Quantification of Immunostained Caspase-9 in Retinal Tissue

Published on: July 25, 2022

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...